part 1. production of pure, homogeneous and stable membrane protein

16
Part 1. Production of Pure, Homogeneous and Stable Membrane Protein Larry Miercke , Rebecca Robbins, Mimi Ho, Andrew Sandstrom*, Rachel Bond, Bill Harries and Robert Stroud Department of Biochemistry and Biophysics, UCSF, San Francisco, CA; *Present address is Biochemistry & Molecular Biology, University of Chicago, Chicago, IL This work was supported by NIH Roadmap grant P50 GM073210 lease e-mail Larry at [email protected] for questions, comments ect.

Upload: norina

Post on 15-Jan-2016

37 views

Category:

Documents


0 download

DESCRIPTION

Part 1. Production of Pure, Homogeneous and Stable Membrane Protein. Larry Miercke , Rebecca Robbins, Mimi Ho, Andrew Sandstrom*, Rachel Bond, Bill Harries and Robert Stroud - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Part 1.  Production of Pure, Homogeneous and Stable Membrane Protein

Part 1. Production of Pure, Homogeneous and Stable Membrane Protein

Larry Miercke, Rebecca Robbins, Mimi Ho, Andrew Sandstrom*, Rachel Bond, Bill Harries and Robert Stroud

Department of Biochemistry and Biophysics, UCSF, San Francisco, CA; *Present address is Biochemistry & Molecular Biology, University of Chicago, Chicago, IL

This work was supported by NIH Roadmap grant P50 GM073210

Please e-mail Larry at [email protected] for questions, comments ect.

Page 2: Part 1.  Production of Pure, Homogeneous and Stable Membrane Protein

Introduction

Our approach to growing quality protein crystals is the production of Pure, Homogeneous and Stable Protein. For it is only when identical crystal building blocks are used that the probability of growing large well ordered crystals is optimized.

Protein production consists of 4 basic steps: membrane preparation, solubilization, purification & chromatographic characterization, and concentration.

Starting with washed membranes, the target is solubilized, then purified to a stable and homogenous state, and finally concentrated while maintaining homogeneity and ultimately minimizing the detergent concentration before entering crystallization trials.

Page 3: Part 1.  Production of Pure, Homogeneous and Stable Membrane Protein

Membrane Preparation: Targets enter the purification workflow once membranes from ≥ 500ml cultures with over-expressed and properly targeted constructs are produced. Most membranes are lysed and washed using a single centrifugation step (harvested cells resuspended directly into high salt buffer prior to lysis, and unwashed pelleted membranes resuspended in glycerol containing buffer). If target proteolysis and protein contaminants are problematic, multiple centrifugation steps are performed (wash cells, lyse in low salt with separate high salt membrane wash; additional steps may include repeated buffer washes and a final sucrose density gradient). A membrane signature gel (series from high to low protein concentration) is run to give an accurate assessment of proteolysis and expression levels, and to determine the membrane concentration required for optimal solubilization screens.

Solubilization: Initial solubilization screens consist of three or up to five different detergents (270mM OG, 20mM DDM and 20mM FC12/FC14/MMPC). All properly targeted constructs tested have been found to be solubilized to >80% by at least one of these detergents. Even though OG is generally poor for extraction, it is always included since it is a favorite for crystallization and function. Additional solubilization screens such as Cymals, sterols, POEs, zwittergents, LDAO, TX-100, and diC6PC will be performed next if required for purification. If solubility, homogeneity and

stability post affinity purification continue to be problematic, a third approach uses mixtures of detergents, alkyl lipids, and cholesterol. It is not until these all fail to produce quality crystals that selective target extraction studies are implemented.

Page 4: Part 1.  Production of Pure, Homogeneous and Stable Membrane Protein

Purification and characterization: Using a combination of affinity, size exclusion and ion exchange chromatography, six key purification parameters (detergent, pH, ionic strength, reducing agent, osmolytes, and additives) are iteratively examined to find a condition which maintains a PHS concentrated population of protein-detergent-complexes or protein-detergent-lipid-complexes. Affinity chromatography is used for purification and detergent exchange, and size exclusion chromatography is used for purification and for assaying homogeneity. Ion exchange chromatography at low and high pH is used for purification, detergent exchange, assaying solubility and homogeneity dependence on pH and ionic strength, and to help determine if the protein is well behaved (a target which chromatographs on multiple formats indicates a well behaved and identically-folded population). Since oligomerization is the major purification problem, analyzing all generated protein fractions throughout the purification by SEC, including the effects of additional additives and sample storage at 4º and -80ºC, is essential to this purification approach.

Concentration: A combination of ultra filtration MWt cut-off filters (centrifugal and high-pressure), chromatography (ion exchange and affinity) and dialysis are all utilized to concentrate protein while minimizing the final detergent concentration. Thin layer chromatography ( is used to estimate the final detergent (and lipid) concentration, while SEC coupled with a tetra detector (absorbance, refraction, viscometer, and light scattering) is used to quantitate the excess micelle concentration while following protein homogeneity and measuring hydrodynamic properties.

The focus of this purification approach is quality output, and requires 3-4 days and 7-14 SEC runs per experiment. It is also used following medium throughput expression and purification screens such as 2 detergents for solubilization and SEC (Savage et al 2008), 1 detergent and SEC condition (Min et al 2009), or 1 detergent and 6 different SEC runs (Stroud Lab, unpublished). Over 67 membrane proteins have been purified to PHS using this approach, and 12 crystal structures solved.

Page 5: Part 1.  Production of Pure, Homogeneous and Stable Membrane Protein

Figure 2. Membrane Signature Gel (Coomassie & Ab, high to low concentration)

CellsLyse (high-pressure homogenizer, bead beater)Low speed & high speed spins to access target incorporation (verses IBs) Washes

Membrane Preparation

Washed Membranes with properly targeted protein

BEWAREAb may not bind if [protein] to high

Especially for Yeast membranes

CoomassieAb

Accurate assessment of proteolysis and expression levelsDetermine [membrane] for optimal solubilization screens

Figure 1. Low speed spin test for membrane incorporation (Zach Newby)

Unincorporated

BS AS

Partial Incorporation

BS AS BS AS

Complete Incorporation

With Tomomi Tsomeya

Page 6: Part 1.  Production of Pure, Homogeneous and Stable Membrane Protein

Well suspended membranes

300μl Vt, centrifuge tube, stir bar (transfer sup to new tube for mixing)

pH 8, 50mM Tris (dictated by first purification step), 300mM NaCl

1 hour, 6 hour, O/N

SDS-PAGE Before and After Spin (BS and AS)

Detergent Solubilization

Figure 3. BS & AS pairs, R to LOG, 1hr*OG, O/N*DDM, 1hr

DDM, 15 hrFC14, 1hrFC14, O/N

*Problematic

Human target

Page 7: Part 1.  Production of Pure, Homogeneous and Stable Membrane Protein

Figure 4. BS & AS pairs, R to L,

of Human target.

Top panel = 1hr, bottom panel = O/N

270 mM OG

20 mM DDM

20 mM FC14

20 mM DDM, 3.2 mM CHS

7 mM DDM, 5 mM CHAPS, 3.2 mM CHS

40 mM C12 Sucrose

Detergent Solubilization cont.

Page 8: Part 1.  Production of Pure, Homogeneous and Stable Membrane Protein

SDSOG DDMLDAOCHAPSTX100 MMPC

FC14SDSDDMMMPCTX100

20mM DDM50mM DDM100mM DDM20mM DDM, 3.2 mM CHS

Figure 5. BS & AS pairs, R to L, of a prokaryotic transporter homolog. Right panel = 15 hr, Left panel = 1 hr(with Tomomi Tsomeya)

Detergent Solubilization cont.

Figure 6. BS & AS pairs, R to L, of a human target. 7mM DDM, 5 mM CHAPS, 3.2 mM CHS20mM FC1420mM FC14, 20 mM DDM20mM FC14, 3.2 mM CHS

Page 9: Part 1.  Production of Pure, Homogeneous and Stable Membrane Protein

Ni/Affinity

Desalt

Tag Cleavage

Cleanup

Size Exclusion

Desalt/pH change

Cation and Anion Exchange

Purification Homogeneity

PurificationpH solubilityDetergent exchangeWell behaved

Purification Detergent Exchange

Parameters Detergent/lipidpHIonic strengthReducing agentOsmolytesAdditives

10/300mm Superdex 2000.75/60cm TSK G3000SW≥ 100mM ionic strength+/- glycerol (5-20% v/v)

HiTrap 1ml, 5ml SP HP, pH 5-6Q HP, pH 8-9Salt gradient, steps

Purification & Characterization

Ni: gravity, 1hr dwell, steps10DG “desalting” columnThrombin, C3 protease, TEVOptional Co, Ni cleanup

Common mobile phases40mM OG, 18mM NG, 8mM DM, 0.5-2mM DDM, 4mM FC12, 0.5mM FC14

Key: assay ALL samples by SE9-15 SE runs/ pass

Usually start with10% glycerol

5mM BME/2mM DTT10DG (3ml/4ml load/elute)Nap 5,10 (0.5ml/1ml, 1ml/1.5ml)

Page 10: Part 1.  Production of Pure, Homogeneous and Stable Membrane Protein

Comment on IE: Beware that multi IE peaks may not be real.Since pH and ionic strength are important parameters involved with homogeneity and stability, running S and Q gradients are performed, initially using SEC purified sample. However, as shown in Figure 6 below, different gradients may be needed to verify that multiple peaks are real, or if they are due to a combined effects of [salt] on micelle and detergent belt size/shape thus giving different detergent-protein ratios and shielding charges used in binding.

Figure 7. S/6/OG profiles of identical injections of a human transporter but eluted using different NaCl gradients.

Serial dilutions

Page 11: Part 1.  Production of Pure, Homogeneous and Stable Membrane Protein

A combination of ultrafiltration, dialysis and chromatography (Ni, IE, SE) is used.Our most popular MWCO (MWt cut-off) membranes are colored in red.

MWCO filters (filter type, method, MWCO)Polyacrylonitrile/polyvinyl chloride (Millipore Amicon XM 50, stir)

Favorite; but no longer available (we still have some boxes)Regenerated cellulose

Stirred cellsAmicon Ultracel YM; 30, 100kDa

Tangential spinAmicon Ultracel YM; 30, 50, 100kDa Sartorius (Vivaspin Hydrosart) 30kDa Orbital Biosciences 60, 150kDa

Polyethersulfone filters (currently retesting, and testing) Stirred cell

Amicon Biomax (PM) 30, 50, 100kDa Pall Omega (modified PES) 30, 50, 100kDa

Tangential spin Amicon Biomax (PM) 30, 50, 100kDa Sartorius (Vivaspin PES) 30, 50, 100kDa PALL Omega 30, 50, 100kDa

Pressure-fugation Sartorius (Vivaspin, Vivacell; spin +/- pressure; pressure + rock)

DialysisChromatography (IE, Ni, SE)

Protein Concentration

Page 12: Part 1.  Production of Pure, Homogeneous and Stable Membrane Protein

Nine Step Expression to Structure Workflow

Experimental Step Value

Structure 9

Diffraction 8

Crystals 7

Pure Homogenous Stable 6

SE, S, Q 5

Tag Cleavage 4

Affinity 3

Solubilization 2

Expression 1

Major Milestones ExpressionPHSStructure

Page 13: Part 1.  Production of Pure, Homogeneous and Stable Membrane Protein

S. cere, HEK, P. past, E. coli, Homologs /E.coli

5.0 12

1.8 2.0 Å

3.8, 3.5, 5.0

High Priority MPEC Protein Scorecard (as of 9-08)

With Corey Anderson, André Bachmann, Sotiri Banakos, Akanksha Bapna, Sarika Chaudhary, Melissa Del Rosario, Vladimir Denic, Robert Edwards, Pascal Egea, Franz Gruswitz, Frank Hays, Joe Ho, David Julius, Monty Krieger, Witek Kwiatkowski, John Lee, Min Li, Bipasha Mukherjee, Vinod Nair, Zach Newby, Roger Nicoll, Sabrina Noel, Joseph O’Connell, Yaneth Robles, Edwin Rodriquez , Zygy Roe-Zurz, Renee Robbins, David Savage, Shimon Schuldiner, Tomomi Tsomeya, Linda Vuong, Jonathan Weismann, and Ronald Yeh.

People with italicized names are no longer working with us.

Page 14: Part 1.  Production of Pure, Homogeneous and Stable Membrane Protein

Solubilization: 100% 20mM DDM, 1hr Purification: 2mM DDM

Ni++: 1mg/L; 1hr 0mM Imidazole bind, 40mM wash, 300mM bumpDesalt into SE buffer: 20mM Tris 8.0, 150mM NaClCleave: 4unit/OD thrombin, O/N, 95-100%Benzamidine: thrombin removal; Co++: uncleaved removalSE/8.0

PHS dilute & conc., 0.3mg/L yield; 5-10mg PHS prepsHomogenous in 0.5mM and 1mM DDM with 10% glycerol

30% lower yields due to enhanced highermersconsider assaying highermers (3 equal populations)

2mM DDM required without 10% glycerol Gives larger yield due to minimal highermersIE

all binds/bumps on S/6/0.5M as single peak; Q/9 goodS/6 best; stay above 20mM NaCl

Concentration: 50kDa maximum MWCO; 50kDa dialysis does not remove DDM; S/6/0.5M/4mM DDM

PureWell-behaved

First S/6

BSAS

FT

40mM

Ni beads

300mM

desalt

Cleave, Co

0.5 mg/ml

T1day

T47day

Homogenous & Stable

7.5mg/ml

1 week

Purification summary of euk12TM/DDM expressed in Yeast

Page 15: Part 1.  Production of Pure, Homogeneous and Stable Membrane Protein

human5TM/OG expressed in HEK293s

Solubilization: 100% 50mM OG, 1hr, whole cell

Purification (40mM OG)

Ab affinity/50mM OG: 10CV wash

200uM peptide bump; 2mg/L yield

Non-cleavable tag

TSK SE: 7-9mg/8L PHS

Binds and bumps on S/6 and Q/9

Optimum stability and function at pH 6

DTT and glycerol not required

Concentration: 50kDa max MWt filter

SDX overlayTime 0 and 49 days

Homogenous & Stable at pH 6.0, 0.3mg/ml

Pure

Reduced Non-reduced

Post Ab/OG Post SE/OG

Serial dilutions

Prep 1

Prep 2

Well behaved

S/6

And at 11.4 mg/ml, 1 week

Page 16: Part 1.  Production of Pure, Homogeneous and Stable Membrane Protein

Solubilization: 100% 200mM OG, O/N (started with 270mM OG)

Purification

40mM OG, 2 mM βME/DTT, 10% glycerol

Ni++: 3mg/L yield; 2hr 35mM Imidazole bind, 40mM wash, 300mM bump

Desalt into Ni buffer: 20mM Tris 8.0, 500mM NaCl

Cleave: TEV, >5x excess, O/N

Co++: TEV removal

SE/7.3: PHS dilute mg/ml; 2-2.5mg/L yield; >20mg PHS preps

IE: all binds and bumps on S/5,6 and Q/7.3, 8, 9 as single peak

single pH 7.3 SE peaks using dilute mg/ml from pH 5-8 (highermers at pH 9)

Concentration

50kDa maximum YM MWt cut-off

Q/7.3/0.3M/40mM OG---8mM excess OG/16.7mg/ml

PDC Properties: 113 moles OG/tetramer, globular (IV=0.05), 4.3 nm Rh, 0.17 dn/dc

proZTM/OG expressed in E.coli

Homogenous & StablePure

SE/7.3 S/5

bump desalt cleaved

BS AS FT

SolNi

Well behaved

Q/7.3

BS AS

Pooled SEC fractions prior to Q/7.316.7 mg/ml post Q/7.3, freeze thawed6mg/ml post dialysis

SDX (pH 7.3, 40mM OG)

280nm

8mM excess OG micelles

PDC

RI

280nm

SDX, 7.3, 40mM OG

Minimized [Detergent]